PATENT CLAIM ANALYSIS

Application Number: 16046429
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["424", "231100"]

Abstract:
The disclosed invention is related to methods, compositions, kits and isolated nucleic acid sequences for targeting Herpes Simplex Virus (HSV) nucleic acid (e.g., HSV-1 and/or HSV-2 nucleic acid). Compositions include amplification oligomers, detection probe oligomers and/or target capture oligomers. Kits and methods comprise at least one of these oligomers.

Claim (Index 35):
The method of  claim 31 , wherein the first detection probe oligomer and/or the second detection probe oligomer further comprises a non-target-hybridizing sequence.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 95.0
- Lexical Diversity: 1.39535
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15487240', '14395039', '14441815', '13642428', '14113880']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8047307969545713
- 35 USC 102 Novelty (BERT): 0.5546864003718551
- Combined Prediction Score: 0.7797263572962997
- Mean Citation Score: 417.629316
- Max Citation Score: 471.57626
- Similarity Product: 292.77290545527575

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test